SAREPTA THERAPEUTICS, INC.
Last · —$16.83+0.32 (+1.94%)live · yahoo · 0s ago
Market cap$1.78B105.6M sh
P/E · TTM6.1fwd — · eps 2.742
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
$14.86$24.45
Volume2.7Msession
| Revenue | $1.4B |
|---|---|
| Operating income | $371.7M |
| Net income | $326.1M |
| Free cash flow | $-8.2M |
| Operating margin | 26.6% |
| Net margin | 23.3% |
| Return on equity | 21.3% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-02
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -38.3%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -11.0%
- Accumulated Deficit High — Accumulated deficit / equity 428%
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
$0.36
Est. revenue
351.2M